Related Experiment Video
Updated: Aug 6, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Oral anticoagulant therapy in patients with peripheral artery disease
F L J Visseren1, B C Eikelboom
1Department of Internal and Vascular Medicine, University Medical Center Utrecht, The Netherlands. F.Visseren@azu.nl
Insights
For peripheral artery disease patients, oral anticoagulants may prevent bypass graft occlusion but increase bleeding risks. Aspirin and clopidogrel are effective for atherothrombotic complications.
Area of Science:
- Vascular Surgery
- Cardiology
- Pharmacology
Background:
- Peripheral artery disease (PAD) patients experience frequent ischemic vascular complications.
- Aspirin and clopidogrel effectively reduce atherothrombotic events in PAD.
- The utility of oral anticoagulants in symptomatic PAD remains limited.
Purpose of the Study:
- To compare the efficacy and safety of oral anticoagulants versus aspirin in PAD patients.
- To evaluate the role of oral anticoagulants in preventing infrainguinal bypass occlusion.
Main Methods:
- Review of randomized controlled trials comparing aspirin with oral anticoagulants.
- Analysis of outcomes including ischemic events, bypass occlusion, and bleeding complications.
Main Results:
- Oral anticoagulants (INR 2.5-4.5) are more effective than aspirin in preventing venous infrainguinal bypass occlusion in high-risk cases.
- The impact of oral anticoagulants on all-cause morbidity and mortality in PAD is not definitively established.
- Increased bleeding complications are associated with oral anticoagulant use.
Conclusions:
- Oral anticoagulants offer a potential benefit for specific high-risk infrainguinal bypass grafts in PAD.
- The increased risk of bleeding complications limits the widespread adoption of oral anticoagulants in PAD management.
- Further research is needed to clarify the overall risk-benefit profile of oral anticoagulants in PAD.
Abstract:
Patients with peripheral artery disease suffer from a high incidence of ischemic vascular complications in coronary, cerebral, and peripheral vascular beds. Reduction of atherothrombotic complications with aspirin or clopidogrel has proven to be successful. The role of oral anticoagulants in patients with symptomatic peripheral artery is limited. Randomized controlled trials comparing the effects of aspirin with oral anticoagulants are scarce. Oral anticoagulants (International Normalized Ratio = 2.5 to 4.5) are more effective than aspirin in preventing infrainguinal bypass occlusion only when venous graft material is used and the bypass is considered to be at high risk for occlusion. Whether the use of oral anticoagulants reduces all-cause morbidity and mortality is not unequivocally clear. The risk of ischemic events is reduced at the expense of an increased number of bleeding complications, which is one of the main reasons that therapy has not been widely adopted.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis III: Interprofessional Care

